Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | DGKA | P23743 | 1/20 | 0.58 |
| ▸ | PRKCA | P17252 | 4/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.52 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.52 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862066 | 1.00 | LMNA (0.68) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19862078 | 1.00 | LMNA (0.68) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19862067 | 1.00 | LMNA (0.68) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL26080034 | 0.92 | MAPT (0.68) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL26080068 | 0.92 | MAPT (0.68) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19862073 | 0.91 | LMNA (0.63) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19862087 | 0.91 | LMNA (0.63) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19862071 | 0.91 | LMNA (0.70) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL25902733 | 0.91 | LMNA (0.70) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL14047346 | 0.91 | LMNA (0.70) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767278-B2 | Plant extract compositions for forming protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230232872-A1 | COMPOUNDS AND FORMULATIONS FOR PROTECTIVE COATINGS | APEEL TECHNOLOGY, INC. | 2023-07-27 | — | — | US | disclosed |
| US-11641865-B2 | Compounds and formulations for protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20180222835-A1 | Plant Extract Compositions for Forming Protective Coatings | APEEL TECHNOLOGY, INC. | 2018-08-09 | — | — | US | disclosed |
| US-20180044276-A1 | PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS | APEEL TECHNOLOGY, INC. | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222835-A1 | Plant Extract Compositions for Forming Protective Coatings | CUTA, SHARPIN, BROX | LMNA 420/4885KDM4E 2706/4885DUSP3 3100/4885 |
| US-11767278-B2 | Plant extract compositions for forming protective coatings | CUTA, SHARPIN, BROX | LMNA 420/4885KDM4E 2706/4885DUSP3 3100/4885 |
| US-20180044276-A1 | PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS | CUTA, SHARPIN, BROX | LMNA 420/4885KDM4E 2706/4885DUSP3 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.